Company: Ash Stevens
Description: Ash Stevens, Inc. is a contract pharmaceutical manufacturer providing comprehensive drug substance development and Active Pharmaceutical Ingredient manufacturing services to companies developing small-molecule innovator drugs.
Website: ashstevens.com
Booth Number: 51A50S
FDA Grants Full Approval for Symptomatic Tenosynovial Giant Cell Tumor Treatment
February 18th 2025Tenosynovial giant cell tumor (TGCT) is rare and non-malignant, forming in or near joints, but which if left untreated can cause damage to joints and surrounding tissue, potentially leading to significant disability.